Transgenic animal model for obesity expressing foxc2

Details for Australian Patent Application No. 2001232599 (hide)

Owner LeanGene AB

Inventors Carlsson, Peter; Enerback, Sven

Agent Davies Collison Cave

Pub. Number AU-B-2001232599

PCT Pub. Number WO01/60853

Priority 0004629 14.12.00 SE; 09587945 06.06.00 US; 0001982 26.05.00 SE; 0000531 18.02.00 SE

Filing date 16 February 2001

Wipo publication date 27 August 2001

Acceptance publication date 12 October 2006

International Classifications

C07K 14/435 (2006.01) Peptides having more than 20 amino acids - from animals

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/575 (2006.01) Peptides having more than 20 amino acids

C12N 15/85 (2006.01) Mutation or genetic engineering - for animal cells

Event Publications

15 June 2006 Assignment before Grant

  Biovitrum AB The application has been assigned to LeanGene AB

12 October 2006 Application Accepted

  Published as AU-B-2001232599

8 February 2007 Standard Patent Sealed

11 September 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001232600

2001232597